SMMRNA: A database of small molecule modulators of RNA

Nucleic Acids Research

Volumn 42, Issue D1, 2014, Pages

  Mehta, Ankita ^a   Sonam, Surabhi ^a   Gouri, Isha ^a   Loharch, Saurabh ^a   Sharma, Deepak K ^a   Parkesh, Raman ^a  

^a INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; LIGAND;

ARTICLE; COMPUTER INTERFACE; CONFORMATION; CRYSTALLIZATION; HYDROGEN BOND; MOLECULAR WEIGHT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROCESS DESIGN; PROCESS OPTIMIZATION; PROTEIN DATABASE; SMMRNA DATABASE; STRUCTURE ACTIVITY RELATION; THREE DIMENSIONAL IMAGING; ANTAGONISTS AND INHIBITORS; CHEMISTRY; CLUSTER ANALYSIS; COMPUTER PROGRAM; DRUG DESIGN; INTERNET; NUCLEIC ACID DATABASE; BINDING AFFINITY; BINDING ASSAY; HIGH THROUGHPUT SCREENING; IC50; RNA STRUCTURE; SMMRNA;

CLUSTER ANALYSIS; DATABASES, NUCLEIC ACID; DRUG DESIGN; INTERNET; LIGANDS; NUCLEIC ACID CONFORMATION; RNA; SOFTWARE;

EID: 84891800880     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt976     Document Type: Article

References (103)

1. Moore, P.B. and Steitz, T.A. (2011) The roles of RNA in the synthesis of protein. Cold Spring Harb. Perspect. Biol., 3, a003780.
2. Walsh, C. (2000) Molecular mechanisms that confer antibacterial drug resistance. Nature, 406, 775.
3. Hermann, T. and Westhof, E. (1998) RNA as a drug target: chemical, modelling, and evolutionary tools. Curr. Opin. Biotechnol., 9, 66-73.
4. Blanchard, S.C., Gonzalez, R.L., Kim, H.D., Chu, S. and Puglisi, J.D. (2004) tRNA selection and kinetic proofreading in translation. Nat. Struct. Mol. Biol., 11, 1008-1014.
5. Noller, H.F. (1991) Drugs and the RNA world. Nature, 353, 302-303.
6. Zapp, M.L., Stern, S. and Green, M.R. (1993) Small molecules that selectively block RNA binding of HIV-1 rev protein inhibit rev function and viral production. Cell, 74, 969-978.
7. Malim, M.H. and Cullen, B.R. (1991) HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. Cell, 65, 241-248.
8. Jensen, K.B., Green, L., MacDougal-Waugh, S. and Tuerk, C. (1994) Characterization of an in vitro-selected RNA ligand to the HIV-1 rev protein. J. Mol. Biol., 235, 237-247.
9. Cooper, T.A., Wan, L. and Dreyfuss, G. (2009) RNA and disease. Cell, 136, 777-793.
10. Perez, B., Ugarte, M. and Desviat, L. (2012) In: Erdmann, V.A. and Barciszewski, J. (eds), From Nucleic Acids Sequences to Molecular Medicine. Springer Verlag, Berlin/Heidelberg, Germany, pp. 357-370.
11. Fiszer, A., Mykowska, A. and Krzyzosiak, W.J. (2011) Inhibition of mutant huntingtin expression by RNA duplex targeting expanded CAG repeats. Nucleic Acids Res., 39, 5578-5585.
12. Galka-Marciniak, P., Urbanek, M.O. and Krzyzosiak, W.J. (2012) Triplet repeats in transcripts: structural insights into RNA toxicity. Biol. Chem., 393, 1299-1315.
13. Hu, J., Liu, J., Yu, D., Chu, Y. and Corey, D.R. (2012) Mechanism of allele-selective inhibition of huntingtin expression by duplex RNAs that target CAG repeats: function through the RNAi pathway. Nucleic Acids Res., 40, 11270-11280.
14. Kiliszek, A., Kierzek, R., Krzyzosiak, W.J. and Rypniewski, W. (2011) Crystal structures of CGG RNA repeats with implications for fragile X-associated tremor ataxia syndrome. Nucleic Acids Res., 39, 7308-7315.
15. Cooper, T.A. (2009) Chemical reversal of the RNA gain of function in myotonic dystrophy. Proc. Natl Acad. Sci. USA, 106, 18433-18434.
16. Warf, M.B., Nakamori, M., Matthys, C.M., Thornton, C.A. and Berglund, J.A. (2009) Pentamidine reverses the splicing defects associated with myotonic dystrophy. Proc. Natl Acad. Sci. USA, 106, 18551-18556.
17. Wheeler, T.M., Leger, A.J., Pandey, S.K., MacLeod, A.R., Nakamori, M., Cheng, S.H., Wentworth, B.M., Bennett, C.F. and Thornton, C.A. (2012) Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature, 488, 111-115.
18. Sicot, G., Gourdon, G. and Gomes-Pereira, M. (2011) Myotonic dystrophy, when simple repeats reveal complex pathogenic entities: new findings and future challenges. Hum. Mol. Genet., 20, 5.
19. Parkesh, R., Childs-Disney, J.L., Nakamori, M., Kumar, A., Wang, E., Wang, T., Hoskins, J., Tran, T., Housman, D., Thornton, C.A. et al. (2012) Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching. J. Am. Chem. Soc., 134, 4731-4742.
20. Watson, L.M. and Wood, M.J. (2012) RNA therapy for polyglutamine neurodegenerative diseases. Expert Rev. Mol. Med., 31, 1.
21. Nakamori, M., Gourdon, G. and Thornton, C.A. (2011) Stabilization of expanded (CTG)*(CAG) repeats by antisense oligonucleotides. Mol. Ther., 19, 2222-2227.
22. Fischbach, M.A. and Walsh, C.T. (2009) Antibiotics for emerging pathogens. Science, 325, 1089-1093.
23. Brandi, L., Fabbretti, A., Milon, P., Carotti, M., Pon, C.L. and Gualerzi, C.O. (2007) Methods for identifying compounds that specifically target translation. Methods Enzymol., 431, 229-267.
24. Lange, R.P., Locher, H.H., Wyss, P.C. and Then, R.L. (2007) The targets of currently used antibacterial agents: lessons for drug discovery. Curr. Pharm. Des., 13, 3140-3154.
25. Kohanski, M.A., Dwyer, D.J. and Collins, J.J. (2010) How antibiotics kill bacteria: from targets to networks. Nat. Rev. Microbiol., 8, 423-435.
26. McCoy, L.S., Xie, Y. and Tor, Y. (2011) Antibiotics that target protein synthesis. Wiley Interdiscip. Rev. RNA, 2, 209-232.
27. Harvey, I., Garneau, P. and Pelletier, J. (2002) Inhibition of translation by RNA-small molecule interactions. RNA, 8, 452-463.
28. Cate, J.H., Yusupov, M.M., Yusupova, G.Z., Earnest, T.N. and Noller, H.F. (1999) X-ray crystal structures of 70S ribosome functional complexes. Science, 285, 2095-2104.
29. Clemons, W.M. Jr, May, J.L., Wimberly, B.T., McCutcheon, J.P., Capel, M.S. and Ramakrishnan, V. (1999) Structure of a bacterial 30S ribosomal subunit at 5.5 A resolution. Nature, 400, 833-840.
30. Brodersen, D.E., Clemons, W.M. Jr, Carter, A.P., Morgan-Warren, R.J., Wimberly, B.T. and Ramakrishnan, V. (2000) The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell, 103, 1143-1154.
31. Carter, A.P., Clemons, W.M., Brodersen, D.E., Morgan-Warren, R.J., Wimberly, B.T. and Ramakrishnan, V. (2000) Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature, 407, 340-348.
32. Wimberly, B.T., Brodersen, D.E., Clemons, W.M. Jr, Morgan-Warren, R.J., Carter, A.P., Vonrhein, C., Hartsch, T. and Ramakrishnan, V. (2000) Structure of the 30S ribosomal subunit. Nature, 407, 327-339.
33. Clemons, W.M. Jr, Brodersen, D.E., Morgan-Warren, R.J., Hartsch, T., Wimberly, B.T. and Ramakrishnan, V. (2001) Crystal structure of an initiation factor bound to the 30S ribosomal subunit. Science, 291, 498-501.
34. Yonath, A. (2002) High-resolution structures of large ribosomal subunits from mesophilic eubacteria and halophilic archaea at various functional States. Curr. Protein. Pept. Sci., 3, 67-78.
35. Ogle, J.M., Brodersen, D.E., Clemons, W.M. Jr, Tarry, M.J., Carter, A.P. and Ramakrishnan, V. (2001) Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science, 292, 897-902.
36. Ogle, J.M., Carter, A.P. and Ramakrishnan, V. (2003) Insights into the decoding mechanism from recent ribosome structures. Trends Biochem. Sci., 28, 259-266.
37. Schmeing, T.M. and Ramakrishnan, V. (2009) What recent ribosome structures have revealed about the mechanism of translation. Nature, 461, 1234-1242.
38. Moore, P.B. and Steitz, T.A. (2003) The structural basis of large ribosomal subunit function. Annu. Rev. Biochem., 72, 813-850.
39. Steitz, T.A. and Moore, P.B. (2003) RNA, the first macromolecular catalyst: the ribosome is a ribozyme. Trends Biochem. Sci., 28, 411-418.
40. Steitz, T.A. (2008) A structural understanding of the dynamic ribosome machine. Nat. Rev. Mol. Cell Biol., 9, 242-253.
41. Dieterich, C. and Stadler, P.F. (2013) Computational biology of RNA interactions. Wiley Interdiscip. Rev. RNA, 4, 107-120.
42. Chou, C.H., Lin, F.M., Chou, M.T., Hsu, S.D., Chang, T.H., Weng, S.L., Shrestha, S., Hsiao, C.C., Hung, J.H. and Huang, H.D. (2013) A computational approach for identifying microRNA-target interactions using high-throughput CLIP and PAR-CLIP sequencing. BMC Genomics, 14(Suppl.1), S2.
43. Kuzu, G., Keskin, O., Gursoy, A. and Nussinov, R. (2012) Expanding the conformational selection paradigm in protein-ligand docking. Methods Mol. Biol., 819, 59-74.
44. Sim, A.Y., Minary, P. and Levitt, M. (2012) Modeling nucleic acids. Curr. Opin. Struct. Biol., 22, 273-278.
45. Moumne, R., Catala, M., Larue, V., Micouin, L. and Tisne, C. (2012) Fragment-based design of small RNA binders: promising developments and contribution of NMR. Biochimie, 94, 1607-1619.
46. Furtig, B., Richter, C., Wohnert, J. and Schwalbe, H. (2003) NMR spectroscopy of RNA. Chembiochem, 4, 936-962.
47. Qin, P.Z. and Dieckmann, T. (2004) Application of NMR and EPR methods to the study of RNA. Curr. Opin. Struct. Biol., 14, 350-359.
48. Furtig, B., Buck, J., Manoharan, V., Bermel, W., Jaschke, A., Wenter, P., Pitsch, S. and Schwalbe, H. (2007) Time-resolved NMR studies of RNA folding. Biopolymers, 86, 360-383.
49. Huber, W. (2005) A new strategy for improved secondary screening and lead optimization using high-resolution SPR characterization of compound-target interactions. J. Mol. Recognit., 18, 273-281.
50. Zhu, Y., Valdes, R. Jr and Jortani, S.A. (2005) Application of bioaffinity mass spectrometry for analysis of ligands. Ther Drug Monit., 27, 694-699.
51. Schug, K.A. (2007) Solution phase enantioselective recognition and discrimination by electrospray ionization-mass spectrometry: state-of-the-art, methods, and an eye towards increased throughput measurements. Comb. Chem. High Throughput Screen, 10, 301-316.
52. Oeffinger, M. (2012) Two steps forward-one step back: advances in affinity purification mass spectrometry of macromolecular complexes. Proteomics, 12, 1591-1608.
53. Tuzimski, T. (2011) Application of different modes of thin-layer chromatography and mass spectrometry for the separation and detection of large and small biomolecules. J. Chromatogr. A, 1218, 8799-8812.
54. Nakayama, H., Takahashi, N. and Isobe, T. (2011) Informatics for mass spectrometry-based RNA analysis. Mass Spectrom. Rev., 30, 1000-1012.
55. Krug, K., Nahnsen, S. and Macek, B. (2011) Mass spectrometry at the interface of proteomics and genomics. Mol. Biosyst., 7, 284-291.
56. Giessing, A.M. and Kirpekar, F. (2012) Mass spectrometry in the biology of RNA and its modifications. J. Proteomics, 75, 3434-3449.
57. DeJong, E.S., Luy, B. and Marino, J.P. (2002) RNA and RNA-protein complexes as targets for therapeutic intervention. Curr. Top. Med. Chem., 2, 289-302.
58. Franceschi, F. and Duffy, E.M. (2006) Structure-based drug design meets the ribosome. Biochem. Pharmacol., 71, 1016-1025.
59. Maxwell, M.M. (2009) RNAi applications in therapy development for neurodegenerative disease. Curr. Pharm. Des., 15, 3977-3991.
60. Coyne, A.G., Scott, D.E. and Abell, C. (2010) Drugging challenging targets using fragment-based approaches. Curr. Opin. Chem. Biol., 14, 299-307.
61. Wu, W. (2010) MicroRNA: potential targets for the development of novel drugs? Drugs R D, 10, 1-8.
62. Collie, G.W. and Parkinson, G.N. (2011) The application of DNA and RNA G-quadruplexes to therapeutic medicines. Chem. Soc. Rev., 40, 5867-5892.
63. Czech, M.P., Aouadi, M. and Tesz, G.J. (2011) RNAi-based therapeutic strategies for metabolic disease. Nat. Rev. Endocrinol., 7, 473-484.
64. Deigan, K.E. and Ferre-D'Amare, A.R. (2011) Riboswitches: discovery of drugs that target bacterial gene-regulatory RNAs. Acc Chem. Res., 44, 1329-1338.
65. Wilson, W.D. and Li, K. (2000) Targeting RNA with small molecules. Curr. Med. Chem., 7, 73-98.
66. Tor, Y. (2003) Targeting RNA with small molecules. Chembiochem, 4, 998-1007.
67. Hermann, T. (2005) Drugs targeting the ribosome. Curr. Opin. Struct. Biol., 15, 355-366.
68. Wu, L., Pan, J., Thoroddsen, V., Wysong, D.R., Blackman, R.K., Bulawa, C.E., Gould, A.E., Ocain, T.D., Dick, L.R., Errada, P. et al. (2003) Novel small-molecule inhibitors of RNA polymerase III Eukaryot Cell, 2, 256-264.
69. Richter, S.N. and Palu, G. (2006) Inhibitors of HIV-1 Tat-mediated transactivation. Curr. Med. Chem., 13, 1305-1315.
70. Thomas, J.R. and Hergenrother, P.J. (2008) Targeting RNA with small molecules. Chem. Rev., 108, 1171-1224.
71. Giri, P. and Kumar, G.S. (2009) Molecular aspects of small molecules-poly(A) interaction: an approach to RNA based drug design. Curr. Med. Chem., 16, 965-987.
72. Aboul-ela, F. (2010) Strategies for the design of RNA-binding small molecules. Future Med. Chem., 2, 93-119.
73. Neelakandan, K., Babu, P. and Nair, S. (2012) Emerging roles for modulation of microRNA signatures in cancer chemoprevention. Curr. Cancer Drug Targets, 12, 716-740.
74. Guan, L. and Disney, M.D. (2012) Recent advances in developing small molecules targeting RNA. ACS Chem. Biol., 7, 73-86.
75. Kumar, G.S. (2012) RNA targeting by small molecules: binding of protoberberine, benzophenanthridine and aristolochia alkaloids to various RNA structures. J. Biosci., 37, 539-552.
76. Liu, X., Liu, L., Xu, Q., Wu, P., Zuo, X. and Ji, A. (2012) MicroRNA as a novel drug target for cancer therapy. Expert Opin. Biol. Ther., 12, 573-580.
77. Mackowiak, G., Jens, S.D., Maaskola, J., Kuntzagk, A., Rajewsky, N., Landthaler, M. and Dieterich, C. (2012) doRiNA: a database of RNA interactions in post-transcriptional regulation. Nucleic Acids Res., 40, D180-D186.
78. Augustin, R., Endres, K., Reinhardt, S., Kuhn, P.H., Lichtenthaler, S.F., Hansen, J., Wurst, W. and Trumbach, D. (2012) Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10. BMC Med. Genet., 13, 35.
79. Cao, Y., Wu, J., Liu, Q., Zhao, Y., Ying, X., Cha, L., Wang, L. and Li, W. (2010) sRNATarBase: a comprehensive database of bacterial sRNA targets verified by experiments. RNA, 16, 2051-2057.
80. Cerami, E.G., Gross, B.E., Demir, E., Rodchenkov, I., Babur, O., Anwar, N., Schultz, N., Bader, G.D. and Sander, C. (2011) Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res., 39, D685-D690.
81. Chen, X., Liu, M.X. and Yan, G.Y. (2012) RWRMDA: predicting novel human microRNA-disease associations. Mol. Biosyst., 8, 2792-2798.
82. Cho, S., Jang, I., Jun, Y., Yoon, S., Ko, M., Kwon, Y., Choi, I., Chang, H., Ryu, D., Lee, B. et al. (2013) MiRGator v3.0: a microRNA portal for deep sequencing, expression profiling and mRNA targeting. Nucleic Acids Res., 41, D252-D257.
83. Cannone, J.J., Subramanian, S., Schnare, M.N., Collett, J.R., D'Souza, L.M., Du, Y., Feng, B., Lin, N., Madabusi, L.V., Muller, K.M. et al. (2002) The comparative RNA web (CRW) site: an online database of comparative sequence and structure information for ribosomal, intron, and other RNAs. BMC Bioinformatics, 3, 2.
84. Cvitkovic, I. and Jurica, M.S. (2013) Spliceosome database: a tool for tracking components of the spliceosome. Nucleic Acids Res., 41, D132-D141.
85. George, A.D. and Tenenbaum, S.A. (2011) Web-based tools for studying RNA structure and function. Methods Mol. Biol., 703, 67-86.
86. Pang, K.C, Stephen, S., Dinger, M.E., Engstrom, P.G., Lenhard, B. and Mattick, J.S. (2007) RNAdb 2.0-an expanded database of mammalian non-coding RNAs. Nucleic Acids Res., 35, D178-D182.
87. Supekar, K. (2010) 2D Chemical Structure Editor. Masters Thesis. University of Pune.
88. Wang, R., Fu, Y. and Lai, L. (1997) A new atom-additive method for calculating partition coefficients. J. Chem. Inf. Comput. Sci., 37, 615-621.
89. Cheng, T., Zhao, Y., Li, X., Lin, F., Xu, Y., Zhang, X., Li, Y., Wang, R. and Lai, L. (2007) Computation of octanol-water partition coefficients by guiding an additive model with knowledge. J. Chem. Inf. Model., 47, 2140-2148.
90. Edwards, M.P. and Price, DA. (2010) Role of physicochemical properties and ligand lipophilicity efficiency in addressing drug safety risks. Annu. Rep. Med. Chem., 45, 381-391.
91. Lipinski, CA., Lombardo, F., Dominy, B.W. and Feeney, P.J. (2012) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliver Rev., 64, 4-17.
92. Corey, R.B. and Pauling, L. (1953) Molecular models of amino acids, peptides, and proteins. Rev. Sci. Instrum., 24, 621-627.
93. Koltun, W.L. (1965) Space filling atomic units and connectors for molecular models, Washington, DC, USA, U. S. Patent 3170246.
94. Backman, T.W., Cao, Y. and Girke, T. (2011) ChemMine tools: an online service for analyzing and clustering small molecules. Nucleic Acids Res., 39, W486-W491.
95. Hawkins, P.C., Skillman, A.G., Warren, GL., Ellingson, BA. and Stahl, M.T. (2010) Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database. J. Chem. Inf. Model., 50, 572-584.
96. O'Boyle, N.M., Banck, M., James, CA., Morley, C, Vandermeersch, T. and Hutchison, GR. (2011) Open Babel: an open chemical toolbox. J. Cheminform., 3, 33.
97. Lewis, K. (2013) Platforms for antibiotic discovery. Nat. Rev. Drug Discov., 12, 371-387.
98. Lipinski, CA., Lombardo, F., Dominy, B.W. and Feeney, P.J. (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 46, 3-26.
99. Lagorce, D., Maupetit, J., Baell, J., Sperandio, O., Tuffery, P., Miteva, MA., Galons, H. and Villoutreix, B.O. (2011) The FAF-Drugs2 server: a multistep engine to prepare electronic chemical compound collections. Bioinformatics, 27, 2018-2020.
100. Baell, J.B. and Holloway, GA. (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J. Med. Chem., 53, 2719-2740.
101. Downs, GM. and Barnard, J.M. (2002) Clustering methods and their uses in computational chemistry. In: Lipkowitz, B.K. and Boyd, B.D. (eds), Reviews in Computational Chemistry, Vol 18. John Wiley and Sons, Wiley-VCH, New Jersey, USA, pp. 1-40.
102. Wild, D.J. and Blankley, C.J. (1999) VisualiSAR: a web-based application for clustering, structure browsing, and structure-activity relationship study. J. Mol. Graphics Model., 17, 85-89.
103. Nicholls, A., McGaughey, GB., Sheridan, R.P., Good, A.C, Warren, G, Mathieu, M., Muchmore, S.W., Brown, S.P., Grant, JA., Haigh, JA. et al. (2010) Molecular shape and medicinal chemistry: a perspective. J. Med. Chem., 53, 3862-3886.